Home / Health / Malaria Fight Boosted by Restored US Funds
Malaria Fight Boosted by Restored US Funds
9 Jun
Summary
- Gavi hopes to use $600 million in US funding for malaria and other vaccinations.
- The funds were previously withheld by the US Health Secretary.
- The US funding is also tied to Gavi phasing out thimerosal in vaccines.
The global vaccine group Gavi is poised to receive $600 million in U.S. funding, which was previously withheld. This significant financial boost is expected to be allocated towards enhancing malaria prevention and other vital vaccination programs worldwide.
The restored funds, approved by Congress for 2025 and 2026, were initially held back by U.S. Health Secretary Robert F. Kennedy Jr. Concerns over Gavi's vaccine safety practices were cited without evidence. Future U.S. funding commitments remain uncertain.
A key condition for the U.S. funding is Gavi's accelerated transition to vaccines that do not contain thimerosal, a mercury-based preservative. Gavi asserts this shift was already underway as part of its commitment to providing advanced healthcare solutions.
